Abstract
To investigate whether the T cell defective capacity to proliferate observed in systemic lupus erythematosus (SLE) T cells is a possible consequence of an intrinsic T cell disorder, the integrity of the accessory activation pathway mediated through CD26 antigen in SLE T cells was studied. Hyporesponsiveness of peripheral blood mononuclear cells (PBMC) from SLE to PHA and CD26 Mab was observed and no differences were found when the responsiveness of highly purified T cells to IL-2, IL-2 plus CD26 Mab, phorbol 12-myristate 13-acetate (PMA), or when PMA plus CD26 Mab was analyzed. Findings suggest that signals induced by triggering CD26 are not intrinsically altered in SLE T cells. However, some alteration of the regulatory involvement of monocytes or B cell over T cell function may be involved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibodies, Monoclonal / pharmacology
-
Antigens, Differentiation, T-Lymphocyte / immunology
-
Antigens, Differentiation, T-Lymphocyte / physiology*
-
Dipeptidyl Peptidase 4
-
Humans
-
Interleukin-2 / pharmacology
-
Lupus Erythematosus, Systemic / blood
-
Lupus Erythematosus, Systemic / immunology
-
Lupus Erythematosus, Systemic / physiopathology*
-
Lymphocyte Activation / drug effects
-
Lymphocyte Activation / immunology
-
Lymphocyte Activation / physiology*
-
Middle Aged
-
Signal Transduction / drug effects
-
Signal Transduction / physiology*
-
T-Lymphocytes / immunology
-
T-Lymphocytes / physiology*
-
Tetradecanoylphorbol Acetate / pharmacology
Substances
-
Antibodies, Monoclonal
-
Antigens, Differentiation, T-Lymphocyte
-
Interleukin-2
-
Dipeptidyl Peptidase 4
-
Tetradecanoylphorbol Acetate